61755-0008 LIBTAYO - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

61755-0008

Brand Name:

LIBTAYO

Generic Name:

cemiplimab-rwlc

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: CEMIPLIMAB

Strength: 50.0

Unit: mg/mL

Packages:

Code: 61755-0008-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (61755-008-01) / 7 mL in 1 VIAL, SINGLE-USE

Effective Date: Sept. 28, 2018

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-1

Orphan Drug Designation:

Status:

In Use